Ironwood Pharmaceuticals, Inc.
(NASDAQ: IRWD) will present a corporate update at the Goldman Sachs 35
Annual Global Healthcare Conference on Wednesday, June 11, 2014 at 2:00 p.m. Pacific Time/5:00 p.m. Eastern Time at the Terranea Resort in Rancho Palos Verdes, Calif.
A live webcast of Ironwood's presentation will be accessible through the Investors section of the company's website at
. To access the webcast, please log on to the Ironwood website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Ironwood's website for 14 days following the conference.
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (NASDAQ: IRWD) is focused on creating medicines that make a difference for patients, building value to earn the continued support of our fellow shareholders, and empowering our team to passionately pursue excellence. We discovered, developed and are commercializing linaclotide, which is approved in the United States and a number of other countries. Our pipeline priorities include exploring further opportunities for linaclotide, as well as leveraging our therapeutic expertise in gastrointestinal disorders and our pharmacologic expertise in guanylate cyclases to address patient needs across the upper and lower gastrointestinal tract. Ironwood was founded in 1998 and is headquartered in Cambridge, Mass. Connect with us at
or on Twitter at
; information that may be important to investors will be routinely posted in both these locations.